(Q24563217)

1

0 references

E M Dwyer

2

0 references

J S Hochman

3

0 references

J S Steinberg

4

0 references

D S Echt

5

0 references

R W Peters

6

0 references

language of work or name

English

0 references

publication date

December 1995

0 references

published in

British Heart Journal

1 reference

Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators

volume

74

0 references

issue

6

0 references

page(s)

631-5

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484119

Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484119

Circadian variation and triggers of onset of acute cardiovascular disease

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484119

CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484119

The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=484119

Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog

30 May 2018

1 reference

12 December 2020

Malignant arrhythmias and acute myocardial ischemia: Interaction between flecainide and the autonomic nervous system

1 reference

12 December 2020

Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death

1 reference

12 December 2020

Flecainide versus quinidine: Results of a multicenter trial

1 reference

12 December 2020

Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death

1 reference

12 December 2020

Safety of encainide for the treatment of ventricular arrhythmias

1 reference

12 December 2020

Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden dea

1 reference

12 December 2020

Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation

1 reference

12 December 2020

Antiarrhythmic drug therapy for suppression of ventricular arrhythmia: experience with 122 patients treated for two years

1 reference

12 December 2020

Malignant ventricular tachyarrhythmias associated with the use of encainide

1 reference

12 December 2020

Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study).

1 reference

https://api.crossref.org/works/10.1136%2FHRT.74.6.631

7 January 2021

Nonfatal cardiac events and recurrent infarction in the year after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1136%2FHRT.74.6.631

7 January 2021

Risk stratification and survival after myocardial infarction

1 reference

https://api.crossref.org/works/10.1136%2FHRT.74.6.631

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1136%2FHRT.74.6.631

7 January 2021

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

https://api.crossref.org/works/10.1136%2FHRT.74.6.631

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1136%2FHRT.74.6.631

7 January 2021

Identifiers

DOI

10.1136/HRT.74.6.631

1 reference

1 reference

1 reference

PubMed publication ID

8541168

1 reference